Filed before 2025Filed 11 October 2022
MOAT BIOTECHNOLOGY Corp has sold $1.5M so far
MOAT BIOTECHNOLOGY Corp, a biotech company based in Oklahoma City, OK, has sold $1.5M so far in its debt round, according to a filing dated 11 October 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 11 October 2022
- First filed
- 21 September 2022
- Round
- Debt round (amended filing)
- Amount sold
- $1.5M
- Offering size
- $1.5M
- Investors so far
- 2
- Based in
- Oklahoma City, OK
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 10% of the 1,764 tracked raises with an amount filed in 2022, and than 11% of the 142 in biotech.
MOAT BIOTECHNOLOGY Corp in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 20 Oct 2025 | New filing | $26.4K | Not tracked |
| 9 Feb 2023 | New filing | $102K | Another raise |
| 11 Oct 2022 | Amended filing | $1.5M | This raise |
| 21 Sep 2022 | New filing | $1M | This raise |
More with MPM BioVentures on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.